AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 278 filers reported holding AVANOS MED INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $21,459 | +26.2% | 793 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $17,000 | -41.4% | 793 | -25.1% | 0.00% | -33.3% |
| Q2 2022 | $29,000 | -17.1% | 1,059 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $35,000 | -5.4% | 1,059 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $37,000 | +12.1% | 1,059 | 0.0% | 0.00% | +33.3% |
| Q3 2021 | $33,000 | -15.4% | 1,059 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $39,000 | -15.2% | 1,059 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $46,000 | -6.1% | 1,059 | 0.0% | 0.01% | -16.7% |
| Q4 2020 | $49,000 | +40.0% | 1,059 | 0.0% | 0.01% | +20.0% |
| Q3 2020 | $35,000 | +12.9% | 1,059 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $31,000 | +6.9% | 1,059 | 0.0% | 0.01% | -28.6% |
| Q1 2020 | $29,000 | -19.4% | 1,059 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $36,000 | -10.0% | 1,059 | 0.0% | 0.01% | -22.2% |
| Q3 2019 | $40,000 | -13.0% | 1,059 | 0.0% | 0.01% | -10.0% |
| Q2 2019 | $46,000 | – | 1,059 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,482,743 | $113,908,000 | 6.40% |
| RGM Capital, LLC | 1,984,455 | $91,047,000 | 3.97% |
| Cove Street Capital, LLC | 204,438 | $9,380,000 | 1.66% |
| Millrace Asset Group, Inc. | 41,200 | $1,890,000 | 1.32% |
| Phocas Financial Corp. | 142,037 | $6,516,000 | 1.00% |
| Champlain Investment Partners, LLC | 3,470,935 | $159,246,000 | 0.91% |
| HEARTLAND ADVISORS INC | 231,533 | $10,623,000 | 0.76% |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | 481,042 | $22,070,000 | 0.33% |
| Wakefield Asset Management LLLP | 14,653 | $672,000 | 0.28% |
| S.A. Mason LLC | 6,527 | $299,000 | 0.25% |